NC
AKYA

Nehal Chopra’s Akoya BioSciences AKYA Stock Holding History

Nehal Chopra’s Portfolio AKYA Stock Details AKYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-70,000
Closed -$977K – 79
2021
Q3 		$977K Sell
70,000
-30,000
-30% -$502K 0.13% 69
2021
Q2 		$1.93M Buy
+100,000
New +$2.06M 0.17% 77

Other funds holding AKYA

HEC
Hudson Executive Capital New York $50.9M AUM 22.11% 1-Year Est. Return
BOTOTLSJU
Board of Trustees of The Leland Stanford Junior University Redwood City, California $533M AUM 65.58% 1-Year Est. Return
BWLSA
Blue Water Life Science Advisors Larkspur, California $159M AUM 139.66% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

Nehal Chopra's AKYA Position: Q4 2021 in Review

Nehal Chopra sold out of Akoya BioSciences (AKYA) in Q4 2021, closing a stake of 70,000 shares — an estimated $977K sold.

Nehal Chopra first reported a position in AKYA in Q2 2021 and held it in 2 quarters. The position peaked at $1.93M in Q2 2021. 45 funds tracked by Wall St. Rank hold AKYA as of Q4 2021.

  • Nehal Chopra reported no remaining Akoya BioSciences position as of Q4 2021 after selling out during the quarter.
  • Nehal Chopra sold 70,000 Akoya BioSciences shares in Q4 2021, an estimated $977K.
  • Nehal Chopra first reported a position in Akoya BioSciences in Q2 2021 and held it in 2 quarters.
  • Nehal Chopra's Akoya BioSciences position peaked at $1.93M in Q2 2021.
  • 45 funds tracked by Wall St. Rank held Akoya BioSciences as of Q4 2021.

Based on Ratan Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.